The multiple you list at is decided in the eighteen months before you file, not during the transaction.

by roughly six months, and the market prices the delay. By the time a chief executive decides the group is ready to list on the DFM or ADX, the transaction advisers arrive, the timetable is set, and the founder assumes the work now begins. The work should have begun eighteen to twenty-four months earlier. What buyers pay a premium for is not built during a bookbuild. It is built quietly in the runway before anyone drafts a prospectus, and a group that starts the runway short arrives at the door underpriced.

and it is the one thing you cannot manufacture in a hurry. Both the DFM and the ADX require a three-year audited financial history prepared to IFRS before you can list. If your accounts have been kept to a local or management standard, the clock on producing three clean comparative years under IFRS starts the day you begin, not the day you decide to list. A group that discovers this late loses the one asset it cannot buy back: time. Everything else in readiness can be accelerated with effort and capital. The audit history cannot.

long before the roadshow. Public-market investors pay up for boards that function, for an audit committee with genuine independence, for internal controls that survive scrutiny, and for a related-party history that does not need explaining away. In a founder-led or family-owned healthcare group, these structures usually exist informally or not at all, and standing them up convincingly takes many months of real operation, not a memo issued the week before filing. Investors can tell the difference between governance that has been lived and governance that was assembled for the prospectus. The former commands the multiple; the latter invites the discount.

rather than a slide you write. The equity story that earns a premium, why this group, why healthcare in this market, why now, has to be evidenced by the numbers the audit will show and consistent with how the business has actually been run. A story that first appears in the offering document reads as retrofitted, and analysts price that skepticism straight into the range. The runway is where you align the operating record with the story you intend to tell, so that by the time investors hear it, the accounts already corroborate it.

for regional listings, not a virtue to signal at the end. GCC investors and the exchanges increasingly expect a credible sustainability position at the point of listing, and a group that treats it as a late compliance task lists with a visible gap. The baseline, the material metrics, the governance around them, the disclosures aligned to what regional capital now expects, takes time to stand up with data behind it. Built into the runway it strengthens the story. Bolted on at the end it weakens it.

is where we start, because you cannot fix what you have not measured against the standard the market will hold you to. The diagnostic tests the group across the dimensions that decide the multiple: the audit and IFRS position, board and committee structure, internal controls, related-party exposure, the equity narrative, the ESG baseline, management depth and the reporting infrastructure a public company has to run. It produces a candid read of where you stand and a sequenced plan to close each gap inside the runway. The output is a committed view of what to fix and in what order, not a list of things to consider.